Medallion Financial Corp. (NASDAQ:MFIN) tinted loss of -1.29% (-0.09 points) to US$6.89. The volume of 0.19 Million shares climbed down over an trading activity of 108.35 Million shares. EPS ratio determined by looking at last 12 month figures is -1.98. Over the same time span, the stock marked US$7.29 as its best level and the lowest price reached was US$3.59. The corporation has a market cap of US$155.58 Million.
Medallion Financial Corp. (NASDAQ:MFIN)’s earnings per share has been growing at a -20.9 percent rate over the past 5 year when average revenue increase was noted as 0 percent. The return on equity ratio or ROE stands at -11.5 percent while most common profitability ratio return on investment (ROI) was 0 percent. The company’s institutional ownership is monitored at 21.6 percent. The company’s net profit margin has achieved the current level of 0 percent and possesses 0 percent gross margin.
Daily Analyst Recommendations
A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 1 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 1 think it is Hold. Recently, analysts have updated the overall rating to 2. 1 analysts recommended Overweight these shares while 0 recommended Underweight, according to FactSet data.
Care.com, Inc. (NYSE:CRCM) is worth US$786.3 Million and has recently fallen -1.29% to US$25.21. The latest exchange of 0.22 Million shares is below its average trading activity of 402.06 Million shares. The day began at US$25.68 but the price moved to US$24.83 at one point during the trading and finally capitulating to a session high of US$25.71. The stock tapped a 52-week high of US$25.67 while the mean 12-month price target for the shares is US$25.25.
Currently, the stock carries a price to earnings ratio of 128.62, a price to book ratio of 7.22, and a price to sales ratio of 4.21. For the past 5 years, the company’s revenue has grown 29.1%, while the company’s earnings per share has grown 17.5%. With an institutional ownership near 92.5%, it carries an earnings per share ratio of 0.2.
Inside Look At Analysts Reviews
Latest analyst recommendations could offer little help to investors. The stock is a Buy among 1 brokerage firms polled by Factset Research. At present, 2 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 2 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 2.2.